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Abstract
Background: The nature of complications and outcomes for Ventricular septal defect (VSD) repair differ between
developed and developing countries. Understanding these differences can help optimize patient management
according to geographical location.
Objective: The purpose of this study was to investigate the risk factors associated with in-hospital peri- and
post-surgical complications of VSD repair in a developing country.
Design: A retrospective cohort study.
Setting: A tertiary referral center.
Participants: 117 patients under 18 years of age admitted for surgical closure of ventricular septal defect
between July 1998 and June 2008.
Main Outcomes: Only patients with isolated VSD or VSD associated with acyanotic congenital heart disease
were included. Outcomes were defined as in-hospital minor and major complications and mortality.
Results: Adverse complications occurred in 35.9% (42/117) and death in 3.4% (4/117) of cases. Age >12
months (OR 0.17 13 months-5 years; 0.10 5-18 years), weight >10 kg (OR 0.24 11-20 kg; 0.13>21 kg), and absence
of pulmonary artery hypertension (OR 0.43) were all significantly associated with a reduced rate of adverse events.
A longer stay in intensive care unit/semi-intensive care unit (OR 11.6 5-7 days; OR 6.1 >8 days) and larger size of
ventricular septal defect (OR 5.4 medium size; 3.9 large size) were associated with an increased risk of adverse
events. Infection (20%) and pneumonia (10%) were the commonest complications.
Conclusions and relevance: Age under one year, weight less than ten kilograms, pulmonary artery
hypertension, and moderate to large size ventricular septal defect are more likely to be associated with adverse
outcomes after surgical repair of ventricular septal defect. Infection and pneumonia comprise almost one third of
the total complications, compared to higher arrhythmic events in developed countries. Developing countries have a
distinct spectrum of complications that may be avoidable and treatable.

Keywords: Congenital heart surgery; Ventricular septal defects;

Surgical repair

Abbreviation: VSD: Ventricular Septal Defect; AKUH: Aga Khan

University Hospital; ASD: Atrial Septal Defect; PDA: Patent Ductus
Arteriosus; MS: Mitral Stenosis; MR: Mitral Regurgitation; PS:
Pulmonary Stenosis; AS: Aortic Stenosis; AR: Aortic Regurgitation;
COA: Coarctation of the Aorta; PAH: Pulmonary Artery Hypertension;
AVP: Aortic Valve Prolapsed; PVR: Pulmonary Vascular Resistance;
CHF: Congestive Heart Failure; OR: Odd Ratio

Introduction
Ventricular septal defect (VSD) is the most common congenital
abnormality of the heart, accounting for 25% to 29% of all cases of
congenital heart disease in Pakistan [1,2]. Spontaneous closure of
VSDs occurs in 8.8% to 48%of children, depending on age [3-5], but
surgical correction is required in 32% of cases, of which 91% are the
Perimembranous VSD (PmVSD) type [6]. Although surgical mortality
and morbidity have reduced significantly in developed countries,
especially with the use of less invasive diagnostic procedures [7,8];
surgical outcomes remain poor for patients in a younger age group and
with low weight at the time of surgery [9]. In spite of these data, age and
weight remain controversial risk factors for adverse surgical outcome
for children with VSD, with some studies suggesting that these factors
are less important, particularly in developing countries [10,11]. The
types of anatomic defects and hemodynamic factors in VSD in relation
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to operative outcome have not been studied for patients treated in
Pakistan. Therefore the purpose of this study was to comprehensively
evaluate the demographic, morphologic, and hemodynamic aspects
of VSD and their associations with surgical outcome, and assess the
spectrum of complications occurring in a developing country tertiary
referral center.

Patients and Methods
Study population
Aga Khan University Hospital (AKUH), Karachi, Pakistan,
is a tertiary referral center for pediatric surgery. We performed a

*Corresponding author: Bushra Omair, Division of Pediatric Cardiology, The
Aga Khan University Hospital, Stadium Road, Karachi, 74800, Pakistan, Tel:
919-519-9583; E-mail: bushraomair@gmail.com
Received July 15, 2013; Accepted September 17, 2013; Published September
20, 2013
Citation: Bushra O, Muneer AM, Mehnaz A (2013) Surgical Outcomes of Pediatric
Patients with Ventricular Septal Defects in a Tertiary Referral Center in Pakistan:
A Retrospective Cohort Study. J Clin Exp Cardiolog 4: 269. doi:10.4172/21559880.1000269
Copyright: © 2013 Bushra O, et al. This is an open-access article distributed under
the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and
source are credited.

Volume 4 • Issue 10 • 1000269

Citation: Bushra O, Muneer AM, Mehnaz A (2013) Surgical Outcomes of Pediatric Patients with Ventricular Septal Defects in a Tertiary Referral
Center in Pakistan: A Retrospective Cohort Study. J Clin Exp Cardiolog 4: 269. doi:10.4172/2155-9880.1000269

Page 2 of 5
retrospective cohort study of 117 consecutive pediatric patients
admitted for surgical closure of a VSD. Patients aged from birth to 18
years of age were identified in the ten-year period between July 1998
and June 2008. Approval for the study was granted from the ethics
committee and institutional review board of AKUH.

Eligibility
All patients diagnosed with isolated VSD or VSDs associated with
acyanotic heart disease-like atrial septal defect (ASD), patent ductus
arteriosus (PDA), mitral stenosis (MS), mitral regurgitation (MR),
pulmonary stenosis (PS), aortic stenosis (AS), aortic regurgitation (AR)
or coarctation of the aorta (COA), and who subsequently underwent
surgery, were included in the study. Patients with VSDs associated with
complex cardiac lesions such as double-outlet ventricle, tetralogy of
fallot, transposition of the great arteries, pulmonary atresia, tricuspid
atresia, truncus arteriosus or single ventricle were excluded from the
study.

Data collection procedures
The patient records of AKUH were queried in order to collect data
on patients meeting the stated criteria. For each patient the number
of VSD, type of VSD, size of VSD, associated diagnosis with VSD, and
outcomes were collected.

Diagnostic criteria and variables
All patients were diagnosed using transthoracic echocardiography
performed by a pediatric cardiologist. For this study, VSD was classified
as PmVSD, muscular, inlet, and doubly committed subarterial/
supracristal VSD. If a patient had more than one type of VSD, then
only the larger-sized VSD was considered in the analysis. The size of the
VSDs were categorized as small, moderate, and large if the VSD was less
than 1/3, between 1/3 and 2/3, or more than 2/3 of the aortic root size,
respectively. If a patient had multiple VSDs, then the sizes were added.
The transthoracic echocardiography report was available in 115 out of
117 patients, and the size of VSD could not be categorized according
to aortic root size in 22 out of 117 patients. Cardiac catheterization
is done in 43 patients. No of patients with available information for
demographic and morphologic data are mentioned in Table 3.
A pediatric cardiologist and cardiac surgeon preformed the
preoperative clinical evaluation and laboratory tests. The pediatric
cardiologist assessed pulmonary artery hypertension (PAH) using a
combination of echocardiography and cardiac catheterization, which
was also performed to investigate potential reversibility of PAH and to
rule out complex cardiac morphology in selected cases. If infection was
identified, patients received antibiotics and surgery was delayed for four
weeks.

Main outcome measures
Outcomes were determined in the time between surgery and
discharge from hospital. Minor and major complications and death
were considered as a single category of “adverse outcome”. In-hospital
complications included significant residual lesion, ventricular
dysfunction, pericardial effusion, pericarditis, pericardial tamponade,
right bundle branch block, transient heart block, transient rhythm
abnormalities, insertion of permanent pacemaker for complete heart
block, pleural effusion, pneumonia, lung collapse, pneumothorax, need
for redo-surgery, neurological complications (such as seizures), renal
insufficiency, infection, re-intubation, cardiopulmonary resuscitation,
and gastrointestinal bleeding. A favorable outcome was defined as a
patient discharged with no complications as defined above. Mortality
J Clin Exp Cardiolog
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was defined as peri-operative or post-operative death before discharge
from hospital.

Statistical analysis
The dependent variable was binary: adverse event or no adverse
event. The following independent variables were used to identify risk
factors for adverse events. Within each independent variable group,
one subgroup was selected as the reference to calculate odds ratio (OR)
for adverse events for the other subgroups relative to the reference
group: age <12 months for “age”, <5 kg for “weight”, yes for “PAH”,
1-1.5 for “Qp:Qs”, 0.5-1.5 for “pulmonary vascular resistance (PVR)”,
0-4 days for “duration of stay in Intensive care unit/semi-intensive care
unit(ICU/SICU)”, perimembranous for “VSD type”, single for “number
of VSDs”, small for “size of VSD”, and yes or ASD for “associated defect”.
Data for each group of variables are presented as OR comparing each
subgroup to its respective reference subgroup; ORs were determined
using the 2-way contingency table chi-square test. Bias was reduced by
considering all patients within the study period, which also determined
the study size. Missing data were excluded from the analysis. Values of
p<0.05 were considered significant. Data were analyzed using SPSS for
Windows (IBM Inc.) version 16.0.

Results
A total of 117 patients underwent open-heart surgery for the repair
of VSD. The baseline clinical characteristics of the patients are shown
in Table 1.
The distribution of demographics, types of morphologic defect
and hemodynamic factors are shown in Table 2. PmVSD was the
most common type of defect, identified in 65% (75/115) of patients,
followed by supracristal VSD (22%; 25/115), muscular VSD (9%;
10/115), and inlet-type VSD (3%; 4/115). One patient was diagnosed
with a Gerbodes-type VSD. A single VSD was found in 94% of patients
(108/115). The VSD was small in 24.2% (23/95), medium sized in 33.7%
(32/95), and large in 42.1% (40/95) of patients. VSDs were associated
with other congenital cardiac defects in 65% (76/117) of cases. The
associated defects were PS (9%; 11/117), ASD (11%; 13/117), PDA
Variable

n

Age (year)

5 yr ± 4 (3 to 17 yr)

Age category
Less than one year

25 (21%)

One to five years

52 (45%)

five to 18 years

40 (34%)

Gender (M:F)
Mean BSA(cm2)

1.3:1.0
0.6

Weight (Kg)

15.5 ± 10.93 (3.1 to 60)

Weight category

14 (12%)

Less than 5 kg
6 to 10 kg

21 (18%)

11 to 20 kg

55 (47%)

More than 21 kg
Genetic syndrome

13 (11%)
15/117 (13%)

Down’s syndrome

10/117 (8.5%)

Qp:Qs ratio

2.3 ± 1.3 (1.0 to 7.0)

Pulmonary vascular resistance index
(Woods unit/m2)

3.4 ± 2.6 (0.5 to 11.3)

PA band before surgery

19/112 (17%)

Stay in ICU/SICU (days)

4 ± 4 (1 to 24)

Duration of intubation (Hours)

20 ± s34 (1 to 211)

Table 1: Clinical characteristics of the patients in this study.
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Adverse outcome

n

%

Ventricular dysfunction

10

9
5

Pericardial effusion

6

Transient heart block

2

2

Transient rhythm abnormality

14

13

Permanent pace maker

1

1

Pleural effusion required
chest tube

8

7

Pneumonia

12

10

Lung collapse

5

4

Need redo surgery

2

2

Seizures

7

6

Infections

22

20

Failure to extubate on
planned day

5

4

CPR

9

8

GIT bleeding

1

1

Intraoperative complications

7

6

Clot in mediastinum

1

1

Total

112

Table 2: Details of the peri- and post-operative complications observed in this
study.

(13%; 15/117), MR (17%; 20/117), and MS in one patient, COA in
two patients, AS in two patients, AR (26%; 30/117), and aortic valve
prolapsed (AVP) (30%; 35/117). Cardiac catheterization was performed
in 37% (43/117) of cases, and 50% (58/117) of patients had PAH. 16%
(19/117) of patients had undergone pulmonary artery banding (PA
band) prior to VSD repair.
Overall, 35.9% (42/117) patients had adverse complications and
death occurred in 3.4% (4/117) of cases. 18% (21/117) of patients
had more than one complication (Table 2). Infections (including
pneumonia) were the most common complication, occurring in 30%
of patients. Transient rhythm abnormalities were the next frequent
complication, occurring in 13% patients.

8.2% only two decades age [8], and much lower than the mortality rates
shown for the same procedure in the Indian subcontinent [10-13].
Variable

n

Adverse
event (n)

Rate of
adverse
event (%)

Odds ratio
(95% CI; p-value)

<12 months

25

19

76

1

13 months-5 years

52

18

35

0.17 (0.06-0.49; 0.0012)

5-18 years

40

10

25

0.10 (0.03-0.34; 0.0001)

<5 kg

14

11

79

1

6-10 kg

21

10

48

0.24 (0.05-1.15; p=0.08)

11-20 kg

55

18

33

0.13 (0.03-0.53; p=0.005)

>21 kg

13

8

62

0.12 (0.03-0.53; p=0.0053)

Yes

58

30

52

1

No

54

17

31

0.43 (0.20-0.93; p=0.03)

1-1.5

12

5

42

1

1.6-2.0

10

2

20

0.35 (0.05-2.4; p=0.28)

2.1-4.0

15

6

40

0.93 (0.19-4.4; p=0.93)

4.1-6.0

2

1

50

1.4 (0.07-28.1; p=0.83)

>6.1

1

1

100

4 (0.13-120.7; p=0.41)

0.5-1.5

7

1

14

1

1.6-3.0

6

1

17

1.2 (0.05-24.5; p=0.91)

3.1-4.5

9

3

33

3 (0.24-37.7; p=0.85)

4.6-6.0

3

1

33

3 (0.24-37.7; p=0.85)

>6.0

2

2

100

21.7 (0.64-730.1; p=0.09)

Age

Weight

PAH

Qp:Qs

PVR

Duration of stay in ICU/SICU
0-4 days

81

20

23

1

5-7 days

24

19

79

11.6 (3.83-35.1; p<0.0001)

>8 days

12

8

67

6.1 (1.7-22.4; p=0.0065)

VSD Type
Perimembranous

75

27

36

1

Age >12 months (OR 0.17 13 months-5 years; 0.10 5-18 years),
weight >10 kg (OR 0.24 11-20 kg; 0.13 >21 kg), and absence of PAH
(OR 0.43) were all significantly associated with a reduced rate of
adverse events (Table 3). A longer stay in ICU/SICU (OR 11.6 5-7 days;
6.1>8 days) and larger size of VSD (OR 5.4 medium size; 3.9 large size)
were significantly associated with an increased rate of adverse events
(Table 3). The inlet type of VSD (OR 15.8) and very high PVR (OR
21.7) demonstrated a trend towards association with adverse events,
although not quite reaching statistical significance.

Muscular

10

5

33

1.7 (0.47-6.70; p=0.39)
15.8 (0.82-306.0; p=0.07)

Patients with VSDs associated with ASD or PDA had an adverse
outcome in 54% and 53% of cases, respectively, followed by AR, MR,
and aortic valve prolapse in 33%, 30%, and 29% of cases, although these
associations were not significant due to small sample sizes.

Inlet

4

4

100

Supracristal VSD

25

9

36

1 (0.39-2.57; p=1.0)

Gerbodes

1

0

0

0.58 (0.02-14.9; p=0.74)

108

44

41

1

7

3

43

1.1 (0.23-5.11; p=0.11)

Number of VSDs
Single
Multiple
Size of VSD
Small

23

4

17

1

Medium

32

17

53

5.4 (1.5-19.4; p=0.01)

Large

40

18

45

3.9 (1.11-13.5; p=0.03)

Yes

76

28

37

1

No

41

19

46

1.5 (0.68-3.1; p=0.32)

Associated defects

Discussion

PS

11

5

45

1

ASD

13

7

54

1.4 (0.27-7.0; p=0.68)

We have shown that patients under one year old, under ten
kilograms, with PAH and moderate to large sized VSDs were more likely
to have an adverse outcome after surgery for repair of VSD. Infection
and pneumonia comprised almost one third of total complications. The
inlet type of VSD had the worst outcomes.

PDA

15

8

53

1.37 (0.39-6.6; p=0.69)

MR

20

6

30

0.51 (0.11-2.4; p=0.39)

MS

1

0

0

0.39 (0.01-11.8; p=0.59)

COA

2

1

50

1.2 (0.06-24.5; p=0.12)

AS

2

0

0

0.24 (0.009-6.0; p=0.38)

AR

30

10

33

0.60 (0.15-5.6; p=0.48)

Prolapse of
coronary cusp

35

10

29

0.48 (0.12-1.94; p=0.30)

In terms of overall outcomes, our in-hospital mortality of 3.4%
was higher than recent published mortality rates for VSD repair in
developed countries. Mortality has been reduced to between 0.5%
and 1.7% [7-9] in Western healthcare systems, which has fallen from
J Clin Exp Cardiolog
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Table 3: Association of demographics, morphology, and hemodynamic factors with
outcome.
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Between 1976 and 1996, perioperative morbidity reduced
significantly from 29% to 15% in children who underwent large VSD
repairs; however, changes in post-operative morbidity have remained
static (approximately 40%; 8). This is comparable to the postoperative
mortality seen in this study, but different in that cardiac dysrhythmia
is the most common complication in developed countries [8], while
infection and pneumonia were most common in our study. Anderson
et al. identified transient or complete heart block, re-operation, and
pleural effusion as the main complications [9], while another study
from the Indian subcontinent also showed infection and pneumonia
to be the most common complication (17%) in the developing country
setting, slightly less than our rate of 31%. These data suggest that the
nature of post-operative complications is different in developing
countries, and may be avoidable and easily treatable.
In our study, other complications were transient heart block (2%),
need for permanent pacemaker (1%), and re-do surgery (2%). This
compares with 3.5% for transient heart block, 2.1% for permanent
pacemaker, and 4.9% for re-do surgery in developed countries [9]. The
need for a chest tube for pleural effusion in 7% of patients and seizures
in 6% of patients compares to 3.5% and 1.7% in developed countries,
respectively [9]. Another study reported a reoperation rate of 2.8% after
surgical closure of an isolated single VSD, and none of these patients
had post-operative heart block, rhythm abnormality, or a neurologic
event [7].
Restrictive VSD is not usually referred for percutaneous or surgical
closure due to the usual natural history of spontaneous closure or
reduction in size. Miyake et al. studied spontaneous closure of VSD
in infants under three month of age, and found spontaneous closure
occurred in72% of cases without congestive heart failure (CHF), but in
only 19% of infants with CHF [5]. Backer et al. evaluated outcomes of
surgical repair for restrictive VSD in a low risk population with a Qp:Qs
ration of less than 2, no PAH, and no symptoms of congestive cardiac
failure. They reported no mortality and no complications such as heart
block, redo surgery, or wound infection [14] in this low risk population.
In our study, complications of VSD repair were higher in patients
with moderate and large VSDs. We did not evaluate confounding risk
factors for adverse outcome according to different sizes of VSD. Since
we followed standard indications for referring patients for surgery,
we assumed that the indication for surgery in restrictive or small to
moderately sized VSDs would be either high Qp:Qs ratio, high PVR,
AVP with regurgitation, or deteriorating clinical condition despite
medical therapy.

respectively, in a low risk population who underwent VSD repair, with
no adverse outcomes [14]. In another study, AR and AVP were found
in 72% and 44% or patients with supracristal VSD undergoing surgical
repair, respectively; this study also showed that the early closure of
the supracristal VSD reduces the progression of AR [15]. These data
suggest that early surgery before the development of AR or AVP not
only reduces the chance of aortic valve replacement, but also reduces
post-operative complications.
A study from India demonstrated that operative weight was not
associated with the length of hospital stay, but that younger age and
preoperative pneumonia required longer post-operative care [10]. In
one study from Pakistan, operations in children under five and younger
age were associated with adverse outcomes [12]. Another study from
a developing country hospital reported no association between age
and post-operative morbidity, but did suggest that this group requires
longer post-operative care [11]. In contrast, Anderson et al determined
that infants under six month of age, and each kilogram decrease in
weight increased composite risk of surgery 1.8 fold [9]. In our study, age
less than one year and weight less than ten kilograms were significantly
associated with higher peri- and post-surgical complications. Anderson
et al. also found that age over six months and higher weights were
associated with reduced incidence of heart block and post-operative
hemorrhage, respectively [9].
More than half of patients had PAH, which was significantly
associated with adverse outcome. Several studies have shown the
association between PAH and higher mortality and morbidity in
patients undergoing VSD repair [12,16]. Surgical repair of small to
moderately size shunts without PAH were the most frequent indication
for surgical repair in the current era and is associated with significantly
lower mortality and morbidity [8].
VSD was associated with ASD and PDA in 10 and 12% of cases
respectively, and more than half of these cases had an adverse outcome,
although these relationships were not statistically significant due to
small subgroup sizes. Other studies have also identified ASD as an
important risk factor for surgical outcome of VSD [17].
Most of the surgical morbidity in our study was due to infection
and pneumonia, which is related to patients’ immune status and
preoperative health. This study helps doctors to counsel families of
high-risk patients about likely post-operative complications. Surgical or
percutaneous repair of moderately sized VSD, regardless of symptoms
and PAH, should be emphasized as a risk and re-evaluated. These data
help doctors understand the need for follow up for medical therapy,
compliance with medication in developing countries, SBE prophylaxis,
reducing loss to follow up, the role of PAH, and factors to help reduce
hospital stays and complications.

We compared our data with the risks and benefits shown for the
operative results of restrictive VSD from Backer et al, and natural
spontaneous closure of VSD without CHF [5,14]. Our data allow us to
conclude that if we repair restrictive or moderately-sized VSDs before
patients develop a high Qp:Qs ratio, higher PVR, or clinical symptoms,
we can reduce the rate of post-operative complications.

Limitations

PmVSDs were observed in 65% of patients, followed by supracristal
VSD in 22% of cases. Associated AR and AVP were present in 26%
and 30% of patients, respectively, and one third of patients with AR
and AVP suffered an adverse outcome. VSD is known to be associated
with AVP in 8.6% of cases and AR in 6.4% of cases [4]. Eroglu et al.
found that none of the VSDs with AVP close spontaneously [4], and
therefore these lesions require surgical intervention. Spontaneous
closure of PmVSD without CHF is 74%, while for supracristal VSD
only 23%, with the remaining VSDs either being small or not requiring
surgery [5]. Backer et al. found AR and AVP in 18% and 45% of cases,

There are several limitations in this study. First, this is a retrospective
study that depended on the written documentation of several doctors,
and therefore there were some missing data that might be difficult to
evaluate. Second, over the ten year of period covered in this analysis,
three different surgeons performed the surgery, with a cardiac surgeon
specialized in pediatric cardiac surgery only starting in 2007. Third,
this study did not differentiate between the high risk and low risk
populations in different sizes and types of VSD repair, and therefore
the question of which complications contribute to high risk moderately
size VSD population remains unanswered. However, overall this study

J Clin Exp Cardiolog
ISSN: 2155-9880 JCEC, an open access journal

Volume 4 • Issue 10 • 1000269

Citation: Bushra O, Muneer AM, Mehnaz A (2013) Surgical Outcomes of Pediatric Patients with Ventricular Septal Defects in a Tertiary Referral
Center in Pakistan: A Retrospective Cohort Study. J Clin Exp Cardiolog 4: 269. doi:10.4172/2155-9880.1000269

Page 5 of 5
provides a comprehensive overview of the problem of risk factors and
outcome in VSD, allowing more focused evaluation in future studies.

Conclusion
Patients aged less than one year, weight under 10 kilograms, PAH,
and moderate to large size VSDs are more likely to develop adverse
outcomes after surgical repair. Infection and pneumonia comprise
almost one third of the total complications in this population treated
in a developing country.
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